CD271 on Melanoma Cell Is an IFN-γ-Inducible Immunosuppressive Factor that Mediates Downregulation of Melanoma Antigens

Journal of Investigative Dermatology - Tập 134 - Trang 1369-1377 - 2014
Junpei Furuta1, Takashi Inozume1, Kazutoshi Harada1, Shinji Shimada1
1Department of Dermatology, University of Yamanashi, Chuo, Yamanashi, Japan

Tài liệu tham khảo

Ahmadzadeh, 2009, Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired, Blood, 114, 1537, 10.1182/blood-2008-12-195792 Boiko, 2010, Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, 466, 133, 10.1038/nature09161 Brahmer, 2012, Safety and activity of anti-PD-L1 antibody in patients with advanced cancer, N Engl J Med, 366, 2455, 10.1056/NEJMoa1200694 Dong, 2002, Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion, Nat Med, 8, 793, 10.1038/nm0902-1039c Dudley, 2002, Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, 298, 850, 10.1126/science.1076514 Hino, 2010, Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma, Cancer, 116, 1757, 10.1002/cncr.24899 Inozume, 2010, Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells, J Immunother, 33, 956, 10.1097/CJI.0b013e3181fad2b0 Johnson, 2009, Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen, Blood, 114, 535, 10.1182/blood-2009-03-211714 Keir, 2008, PD-1 and its ligands in tolerance and immunity, Annu Rev Immunol, 26, 677, 10.1146/annurev.immunol.26.021607.090331 Landsberg, 2012, Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation, Nature, 490, 412, 10.1038/nature11538 Micera, 2007, Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate, Cytokine Growth Factor Rev, 18, 245, 10.1016/j.cytogfr.2007.04.004 Okamoto, 2010, Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth, Mol Cancer Ther, 9, 2333, 10.1158/1535-7163.MCT-09-1147 Palmer, 2008, Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity, Proc Natl Acad Sci USA, 105, 8061, 10.1073/pnas.0710929105 Shibagaki, 2002, Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity, J Immunol, 168, 2393, 10.4049/jimmunol.168.5.2393 Topalian, 2012, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, N Engl J Med, 366, 2443, 10.1056/NEJMoa1200690 Wang, 2005, Generating renal cancer-reactive T cells using dendritic cells (DCs) to present autologous tumor, J Immunother, 28, 551, 10.1097/01.cji.0000175495.13476.1f Zaidi, 2011, The two faces of interferon-gamma in cancer, Clin Cancer Res, 17, 6118, 10.1158/1078-0432.CCR-11-0482